Huge COVID study finds remdesivir doesn’t work—FDA grants approval anyway
WHO says its massive study was clearly not included in FDA review.
Full Article
Huge COVID study finds remdesivir doesn’t work—FDA grants approval anyway
Ars Technica
0 shares
2 views
You might like
Related news coverage
NA Proactive news snapshot: Revive Therapeutics, KULR Technology, Lexaria Bioscience, TRACON Pharmaceuticals UPDATE …
Proactive Investors
Revive Therapeutics Ltd (CSE:RVV) (OTCMKTS:RVVTF) announced Monday that it has committed to 10 clinical sites in the US for its..
-
NA Proactive news snapshot: KWESST Micro Systems, WeedMD, Bragg Gaming Group, MGX Minerals, Phunware, Nextleaf Solutions, Candelaria Mining UPDATE…
Proactive Investors
-
NA Proactive news snapshot: Esports Entertainment Group, CytoDyn, ImagineAR, GlobeX Data …
Proactive Investors
-
US gives full approval for antiviral remdesivir drug to treat COVID-19 patients
Mid-Day
-
FDA approves first COVID-19 drug: antiviral remdesivir
SeattlePI.com
Advertisement
More coverage
Gilead secures FDA approval for remdesivir
US agency grants first regulatory consent for a drug to treat Covid-19 patients
FT.com